Advertisement

Strahlentherapie und Onkologie

, Volume 195, Issue 6, pp 566–567 | Cite as

Combination of brachytherapy and chemotherapy not superior to pelvic radiotherapy according to GOG-249

  • Alexandros PapachristofilouEmail author
  • Tobias Finazzi
Letter to the Editor
  • 124 Downloads

Notes

Compliance with ethical guidelines

Conflict of interest

A. Papachristofilou and T. Finazzi declare that they have no competing interests.

Ethical standards

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Marnitz S et al (2018) Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions? Strahlenther Onkol 194(11):965–974.  https://doi.org/10.1007/s00066-018-1339-6 CrossRefGoogle Scholar
  2. 2.
    de Boer SM et al (2018) Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol 19(3):295–309.  https://doi.org/10.1016/S1470-2045(18)30079-2 CrossRefGoogle Scholar
  3. 3.
    Matei D et al (2017) A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma. J Clin Oncol 35(15_suppl):5505.  https://doi.org/10.1200/jco.2017.35.15_suppl.5505 CrossRefGoogle Scholar
  4. 4.
    Matulonis U et al (2018) Analysis of patient-reported outcomes (PROs) for GOG-258, a randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel (Cis-RT+CP) vs. carboplatin and paclitaxel (CP) for optimally debulked, locally advanced endometrial carcinoma. J clin Oncol 36(15_suppl):5589.  https://doi.org/10.1200/jco.2018.36.15_suppl.5589 CrossRefGoogle Scholar
  5. 5.
    Randall M et al (2017) A phase 3 trial of pelvic radiation therapy versus vaginal cuff Brachytherapy followed by Paclitaxel/Carboplatin chemotherapy in patients with high-risk, early-stage Endometrial cancer: a gynecology oncology group study. Int J Radiat Oncol Biol Phys 99(5):1313.  https://doi.org/10.1016/j.ijrobp.2017.09.008 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Clinic of Radiotherapy & Radiation OncologyUniversity Hospital BaselBaselSwitzerland

Personalised recommendations